title: In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites.
abstract: The species of the genus Acanthamoeba are opportunistic protozoan parasites that cause different diseases in humans, such as amoebic keratitis and granulomatous encephalitis. The rise in the rate of Acanthamoeba keratitis, mainly due to the increase in contact lens wearers, turns the development of viability assays using a multi-well plate reader as a tool for screening new antiamoebic agents in vitro into an important goal. In our study, the viability assays PrestoBlue®, resazurin sodium salt, 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) and CellTiter96® were tested for their suitability as time-saving alternatives to the classical manual or direct-counting method, assessing the effect of the antiamoebic agent chlorhexidine digluconate and temperature on Acanthamoeba castellanii (ATCC® 30234™) and Acanthamoeba polyphaga 2961. Although resazurin and MTT have already been previously used in amoeba viability assays to test the activities of antiamoebic agents in vitro, it is the first time that PrestoBlue® and CellTiter96® are used for this purpose. Results indicated that the viability assays were strain-dependent leading in some cases to an overestimation of the real situation of viable cells. This implies that each viability assay ought to be set up for each amoeba strain studied.
authors.affiliation: Department of Biomedicine and Biotechnology, School of Pharmacy, University of Alcalá, Ctra. Madrid-Barcelona (Autovía A2) Km. 33 600, 28871, Alcalá de Henares, Madrid, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Heredero-Bermejo
authors.forename: J L
authors.initials: JL
authors.lastname: Copa-Patiño
authors.forename: J
authors.initials: J
authors.lastname: Soliveri
authors.forename: R
authors.initials: R
authors.lastname: Gómez
authors.forename: F J
authors.initials: FJ
authors.lastname: de la Mata
authors.forename: J
authors.initials: J
authors.lastname: Pérez-Serrano
mesh_terms: D000048:Acanthamoeba / Q000187:drug effects / Q000254:growth & development*; D015823:Acanthamoeba Keratitis / Q000469:parasitology / Q000517:prevention & control; D048248:Acanthamoeba castellanii / Q000187:drug effects / Q000254:growth & development*; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D002710:Chlorhexidine / Q000031:analogs & derivatives / Q000494:pharmacology; D003261:Contact Lenses; D006801:Humans; D007202:Indicators and Reagents / Q000737:chemistry; D010078:Oxazines / Q000737:chemistry; D013778:Tetrazolium Salts / Q000737:chemistry; D013844:Thiazoles / Q000737:chemistry; D053058:Trophozoites / Q000187:drug effects / Q000254:growth & development; D014966:Xanthenes / Q000737:chemistry
chemical_list: D000981:Antiprotozoal Agents; D007202:Indicators and Reagents; D010078:Oxazines; D013778:Tetrazolium Salts; D013844:Thiazoles; D014966:Xanthenes; C070380:3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; C005843:resazurin; C022616:thiazolyl blue; C010882:chlorhexidine gluconate; D002710:Chlorhexidine
references.citation: J Appl Microbiol. 2009 Aug;107(2):368-78
references.pmid: 19302312
references.citation: J Antimicrob Chemother. 2007 Sep;60(3):521-5
references.pmid: 17623692
references.citation: J Ophthalmol. 2012;2012:484892
references.pmid: 23304449
references.citation: Am J Ophthalmol. 1985 Sep 15;100(3):389-95
references.pmid: 4037025
references.citation: Int J Parasitol. 2004 Aug;34(9):1001-27
references.pmid: 15313128
references.citation: PLoS One. 2013 Apr 11;8(4):e60834
references.pmid: 23593320
references.citation: J Antimicrob Chemother. 1997 Aug;40(2):227-33
references.pmid: 9301988
references.citation: Int J Cancer. 1996 Nov 15;68(4):528-34
references.pmid: 8945626
references.citation: Parasitol Res. 2012 Jun;110(6):2175-80
references.pmid: 22160280
references.citation: Clin Exp Ophthalmol. 2002 Feb;30(1):49-51
references.pmid: 11885797
references.citation: Cancer Detect Prev. 2003;27(1):47-54
references.pmid: 12600417
references.citation: Korean J Ophthalmol. 2003 Jun;17(1):29-34
references.pmid: 12882505
references.citation: Parasitol Int. 2000 Jan;48(3):265-9
references.pmid: 11227767
references.citation: Appl Environ Microbiol. 2000 Mar;66(3):1057-61
references.pmid: 10698771
references.citation: Arch Med Res. 1992;23(2):59-61
references.pmid: 1285086
references.citation: PLoS One. 2013 Jul 02;8(7):e68244
references.pmid: 23844174
references.citation: J Microbiol Methods. 2007 Nov;71(2):101-6
references.pmid: 17888535
references.citation: Parasitol Res. 2012 Jun;110(6):2563-7
references.pmid: 22231263
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Toxicol Appl Pharmacol. 2009 Jan 15;234(2):222-35
references.pmid: 18983864
references.citation: Exp Parasitol. 2010 Sep;126(1):106-8
references.pmid: 20045692
references.citation: J Clin Microbiol. 2005 Feb;43(2):629-34
references.pmid: 15695656
references.citation: Antimicrob Agents Chemother. 2004 Dec;48(12):4520-7
references.pmid: 15561820
references.citation: Folia Parasitol (Praha). 1996;43(1):43-6
references.pmid: 8682409
references.citation: Parasitol Res. 2012 Jan;110(1):167-74
references.pmid: 21626154
references.citation: J Med Microbiol. 2008 Nov;57(Pt 11):1399-1404
references.pmid: 18927419
references.citation: Arch Med Res. 2006 Aug;37(6):723-9
references.pmid: 16824931
references.citation: Curr Microbiol. 2002 Jun;44(6):444-9
references.pmid: 12000996
references.citation: Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2003;21(4):218-20
references.pmid: 14628372
references.citation: J Immunol Methods. 1997 Dec 15;210(1):25-39
references.pmid: 9502582
references.citation: Parasitol Res. 2013 Mar;112(3):961-9
references.pmid: 23263327
references.citation: Parasitol Res. 2006 Jul;99(2):103-7
references.pmid: 16506080
references.citation: Antimicrob Agents Chemother. 2008 Feb;52(2):470-6
references.pmid: 18039920
references.citation: Exp Parasitol. 2012 May;131(1):20-4
references.pmid: 22417972
references.citation: J Immunol Methods. 1998 Apr 15;213(2):157-67
references.pmid: 9692848
references.citation: Proc West Pharmacol Soc. 2011;54:10-4
references.pmid: 22423572
references.citation: FEMS Microbiol Rev. 2006 Jul;30(4):564-95
references.pmid: 16774587
references.citation: Rev Invest Clin. 1994 Sep-Oct;46(5):343-7
references.pmid: 7839013